Description
HAEGARDA MEDICATION
First action · last action
2019-02-12 · 2019-02-12
Transactions
1
First transaction's obligation
$208,978
Base + all options value (sum of deltas)
$208,978
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-02-12+$208,978= $208,978
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-02-12 | +$208,978 | $208,978 | HAEGARDA MEDICATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H3WKVE9VBLY3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826F0207 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $183,903 | FY2026 |
| 36C24826F0187 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $36,781 | FY2026 |
| 36C25226F0318 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $85,484 | FY2026 |
| 36C24826F0091 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $147,122 | FY2026 |
| 36C24826F0037 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $124,240 | FY2026 |
| 36C24824F0327 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $391,583 | FY2024 |
Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0690 | SINA DRUG LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $188,463 | FY2026 |
| 36C24726N0211 | BOSTON SCIENTIFIC CORP | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $248,982 | FY2026 |
| 36C24726F0100 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $228,396 | FY2026 |
| 36C24726F0053 | EXELAN PHARMACEUTICALS INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $4,765,853 | FY2026 |
| 36C24726F0043 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $109,456 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24719F0312_3600_V797D50358_3600 · retrieved 2026-09-26.